Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38721980.
- Also identified by DOI 10.1093/cid/ciae256 and PMC identifier 11797029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this randomized controlled study, individuals taking dolutegravir+darunavir/ritonavir had greater increases in systolic and diastolic blood pressure than those taking 2 nucleoside reverse-transcriptase inhibitors+darunavir/ritonavir at week-48. The difference remained significant after controlling for confounding factors, including weight gain.
Medical subject headings
- Anti-HIV Agents
- Anti-Retroviral Agents
- Antiretroviral Therapy, Highly Active
- Blood Pressure
- HIV Infections